Related Experiment Video
Updated: Jun 21, 2025

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
404
Primary Hepatic Neuroendocrine Carcinoma: A Rare Entity.
Jasmine Tidwell1, Bianca Thakkar1, Minh Thu T Nguyen2
1Department of Medicine, UConn John Dempsey Hospital, Farmington, CT.
ACG Case Reports Journal
|July 12, 2024
Summary
This case study highlights a rare primary hepatic neuroendocrine carcinoma. Prompt diagnosis and intervention are crucial for managing this high-malignancy tumor and preventing fatal outcomes.
Area of Science:
- Oncology
- Gastroenterology
- Pathology
Background:
- Neuroendocrine tumors (NETs) originate from neuroectodermal cells.
- Neuroendocrine carcinomas (NECs) are high-malignancy variants of NETs.
- Primary hepatic NECs are exceptionally rare, with liver NECs often indicating metastasis.
Observation:
- A unique case of incidentally discovered primary hepatic neuroendocrine carcinoma is presented.
- Initial radiological findings were misleading, complicating diagnosis.
- Histopathology confirmed the primary hepatic origin, with imaging excluding extrahepatic sources.
Findings:
- The patient, diagnosed with primary hepatic NEC, opted against surgical intervention.
- The lack of timely intervention led to a fatal outcome.
- This case emphasizes the diagnostic challenges and aggressive nature of primary hepatic NEC.
Implications:
- Accurate and timely diagnosis of primary hepatic NEC is critical.
- Prompt intervention, including surgical consideration, is vital for improving patient prognosis.
- This case contributes to understanding the rarity and management of hepatic NECs.

